PACS Group, Inc. (NYSE: PACS) announced today that it intends to report its financial results for the second quarter ended June 30, 2026, on Tuesday, August 4, 2026, after the stock market closes. Management will host a conference call on Wednesday, August 5, 2026, at 11:30 a.m. ET to discuss the financial results and related information. This schedule provides investors with a clear timeline for accessing the company's latest operational and financial performance data.

Conference Call Details

The company invites current and prospective investors to listen to the call via webcast by visiting the Investors section of the PACS Group website at https://ir.pacs.com/ or by visiting https://event.choruscall.com/mediaframe/webcast.html?webcastid=MSOaC8tI . Investors may also dial 877-407-0621 or 1-215-268-9899 to participate. A recording of the call will be available for replay via the website for 30 days following the call.

About PACS Group

PACS Group, Inc. is a holding company investing in post-acute healthcare facilities, professionals, and ancillary services. Founded in 2013, PACS Group is one of the largest post-acute platforms in the United States. Its independent subsidiaries operate 324 post-acute care facilities across 17 states serving over 31,900 patients daily. More information about PACS is available at https://IR.pacs.com .

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as "expect," "intends," "will," "anticipates," "estimates" and variations of such words and similar future or conditional expressions are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding the Company’s expectation of releasing earnings and holding its earnings call. Forward-looking statements are based on management’s current expectations based on information currently available to the Company. Forward-looking statements are subject to known and unknown risks, uncertainties and assumptions, and actual results or outcomes may differ from those expressed or implied in the forward-looking statements due to various factors. All forward-looking statements speak only as of the date of this press release and, except as required by applicable law, the Company has no obligation to update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

Kaskela Law is investigating PACS Group on behalf of long-term investors to determine if the company's board violated federal securities laws or breached fiduciary duties. The investigation follows a federal securities fraud complaint alleging that PACS and its officers made materially false and misleading statements regarding the company's rapid growth and profitability. The complaint claims this growth was primarily driven by the manipulation of billing practices that exploited taxpayer-funded programs.

The allegations focus on the period between April 11, 2024, and December 16, 2024. On November 4, 2024, Hindenburg Research published a report titled "PACS Group: How to Become A Billionaire In The Skilled Nursing Industry By Systematically Scamming Taxpayers." The report purportedly revealed a COVID-19 Waiver scheme, a Medicare Part B scheme, a licensing scheme, and other misconduct. Following the report's release, PACS shares declined approximately 40% to close at $18.09 on November 6, 2024.

Key Dates and Allegations

The investigation centers on the actions of PACS Group and its officers during the specified timeframe. The following table outlines the critical dates and events mentioned in the complaint.

Kaskela Law is examining whether the members of PACS' board of directors failed in their obligations amidst these alleged schemes. The firm seeks to recover losses for investors who purchased shares prior to the disclosure of the alleged misconduct.

Shareholder Information

Current PACS shareholders who purchased or acquired their shares prior to November 5, 2024, are encouraged to contact Kaskela Law. The firm represents investors in securities fraud and corporate governance litigation on a contingent basis. Interested investors can reach D. Seamus Kaskela, Esq. or Adrienne Bell, Esq. at (484) 229 – 0750 or via email at abell@kaskelalaw.com for additional information regarding their legal rights and options.